South Africa
South Africa Pharmaceuticals with a difference.
With a guiding principle of working to improve your health, we deliver pharmaceuticals that make a real difference in people’s health.
Investor centre
AFT’s product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.
Invest in AFT Pharmaceuticals
We went from ‘go’ to global in under 20 years
Latest news
Keep up to date with the latest news from AFT Pharmaceuticals
November 20, 2025
AFT delivers 10th consecutive first half revenue increase
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…
September 25, 2025
On track for $300m FY27 revenue; positive iron IV study result
– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …
May 26, 2025
AFT and Hikma extend US Maxigesic Cooperation
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
The AFT Pharmaceuticals Journey
Discover our incredible team and culture
Frequently asked questions
Where can I report adverse drug reactions?
Please get in touch with us at safety@zaf.aftpharm.com or go to our Contact Us page.
Where can I find out more about your prescription range?
You can find further information about our prescriptions on the Prescription Range page.
I am interested in partnering with you as a licensee/licensor, how do I get in touch?
Please use the enquiry form on the Contact Us page and someone will be in touch.
How can I work at AFT?
If we have any current vacancies, you can find them on the Careers page.
How do I invest in AFT?
Head to our Investors website to find out more about how you can invest with AFT Pharmaceuticals.